EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Clinical Effectiveness of a Blood-Based Biomarker in Patients with Mild Traumatic Brain Injury

Khemmachat Laovanantaphun, Khrongwong Musikatavorn, Krishnapundha Bunyaratavej iD

Asian Journal of Neurosurgery · 01.09.2026 · 21 (03) · 470-476

DOI: 10.1055/s-0046-1815951 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Asian Journal of Neurosurgery, erschienen am 01.09.2026. Verfasst von Khemmachat Laovanantaphun und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neurosurgery, Department of Surgery, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cro…. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mild traumatic brain injury (mTBI) is among the most prevalent neurological conditions worldwide. Its diagnosis predominantly depends on computed tomography (CT) imaging, despite the majority of scans yielding negative results, leading to unnecessary resource utilization and avoidable radiation exposure. This study aims to investigate the potential of glial fibrillary acidic protein (GFAP) and ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) as serum biomarkers for ruling out clinically significant intracranial injuries. This prospective cohort study enrolled adult patients (aged >18 years) presenting to the emergency department with nonpenetrating mTBI between October 2023 and October 2024. All participants underwent brain CT imaging and venous blood sampling for quantification of GFAP and UCH-L1. Diagnostic performance metrics, including sensitivity, specificity, positive predictive value, and negative predictive value, were calculated to assess biomarker accuracy in detecting intracranial abnormalities. A total of 123 patients were enrolled, with a mean age of 70 years. The predominant mechanism of injury was a ground-level fall. The combined use of GFAP and UCH-L1 demonstrated excellent sensitivity (100%; 95% CI: 89.1–100%) and negative predictive value (100%; 95% CI: 76.8–100%) for detecting intracranial injury. However, specificity was low (15.4%; 95% CI: 8.7–24.5%), indicating limited ability to rule in pathology based on biomarker elevation alone. This study demonstrates the high sensitivity and negative predictive value of GFAP and UCH-L1 as a combined biomarker test for evaluating moderate- and high-risk mTBI. Patients with a negative biomarker result may safely forgo head CT, thereby reducing unnecessary radiation exposure and avoiding unwarranted CT utilization. Nevertheless, practical challenges remain before routine clinical adoption is feasible. Future cost analyses will be essential to determine the economic viability of these biomarkers, particularly in resource-limited settings.

Schlagwörter

Stichwörter der Autor:innen

glial fibrillary acidic proteinhead CT scanmild traumatic brain injuryserum biomarkerstraumatic brain injuryubiquitin C-terminal hydrolase-L1

Autor:innen und Institutionen

  • Division of Neurosurgery, Department of Surgery, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand.
  • Department of Emergency Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, The Thai Red Cross Society, Bangkok, Thailand.

ORCID-Profile: Krishnapundha Bunyaratavej

Zitieren

APA

Laovanantaphun, K., Musikatavorn, K., & Bunyaratavej, K. (2026). Clinical Effectiveness of a Blood-Based Biomarker in Patients with Mild Traumatic Brain Injury. Asian Journal of Neurosurgery, 21(03), 470-476. https://doi.org/10.1055/s-0046-1815951

Vancouver

Laovanantaphun K, Musikatavorn K, Bunyaratavej K. Clinical Effectiveness of a Blood-Based Biomarker in Patients with Mild Traumatic Brain Injury. Asian Journal of Neurosurgery. 2026;21(03):470-476. doi:10.1055/s-0046-1815951

BibTeX
@article{Laovanantaphun2026,
  author = {Laovanantaphun, Khemmachat and Musikatavorn, Khrongwong and Bunyaratavej, Krishnapundha},
  title = {Clinical Effectiveness of a Blood-Based Biomarker in Patients with Mild Traumatic Brain Injury},
  journal = {Asian Journal of Neurosurgery},
  year = {2026},
  volume = {21},
  number = {03},
  pages = {470--476},
  doi = {10.1055/s-0046-1815951}
}
Kostenlos starten →